Two Swords in the Storm: Parvovirus B19 and COVID-19 Clash in a Myocardial Mayhem of Arrhythmias

References (26)

1. 1 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases [DOI]
2. 2 Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) [DOI]
3. 3 Myocarditis and inflammatory cardiomyopathy: current evidence and future directions [DOI]
4. 4 Myocardial Localization of Coronavirus in COVID-19 Cardiogenic Shock [DOI]
5. 5 Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin [DOI]
6. 6 First case of COVID-19 complicated with fulminant myocarditis: a case report and insights [DOI]
7. 7 Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 [DOI]
8. 8 The Variety of Cardiovascular Presentations of COVID-19 [DOI]
9. 9 Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection [DOI]
10. 10 COVID-19-related myocarditis in a 21-year-old female patient [DOI]
11. 11 Human Parvovirus B19–Associated Myocarditis [DOI]
12. 12 The management of myocarditis [DOI]
13. 13 Detection of Viral SARS-CoV-2 Genomes and Histopathological Changes in Endomyocardial Biopsies [DOI]
14. 14 Recent Advances in Replication and Infection of Human Parvovirus B19 [DOI]
15. 15 Delayed Acute Myocarditis and COVID-19-Related Multisystem Inflammatory Syndrome [DOI]
16. 16 The prevalence of antibody to human parvovirus B 19 in England and Wales [DOI]
17. 17 Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. [DOI]
18. 18 Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples [DOI]
19. 19 Takotsubo cardiomyopathy and COVID-19 infection [DOI]
20. 20 Clinically Suspected and Biopsy-Proven Myocarditis Temporally Associated with SARS-CoV-2 Infection [DOI]
21. 21 Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG [DOI]
22. 22 Coinfection of Parvovirus B19 with Influenza A/H1N1 Causes Fulminant Myocarditis and Pneumonia. An Autopsy Case Report [DOI]
23. 23 Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients.
24. 24 Primary Epstein–Barr virus infection and probable parvovirus B19 reactivation resulting in fulminant hepatitis and fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis [DOI]
25. 25 Réactivation d’une infection à parvovirus B19 chez une patiente infectée par le VIH [DOI]
26. 26 A Rare Case of Parvovirus B19 Infection Manifesting as Chronic Aplastic Anemia and Neutropenia in a Human Immunodeficiency Virus-Infected Patient [DOI]

Cited by 0

No indexed citations yet.

Related research

• Sudden Cardiac Death — shares topic coverage
• Myocarditis and Autoimmune Disease Development Following Bariatric Surgery: A Possible Nutritional Deficiency Link — shares topic coverage
• Myocarditis during SARS-CoV-2 Infection: A Series of 15 Cases — shares topic coverage
• Death Due to Low Voltage Electric Shock Induced Myocarditis — shares topic coverage
• Serial Electrocardiographic Changes in a Young Female with Acute Myocarditis — shares topic coverage